Building Capacity to Increase Commercial Tobacco Cessation | CDC RFA DP 24 0056

Opportunity Information: Apply for CDC RFA DP 24 0056

Building Capacity to Increase Commercial Tobacco Cessation (CDC RFA DP 24 0056) is a CDC Office on Smoking and Health funding opportunity focused on improving how states, territories, and their partners help people quit commercial tobacco. The premise is straightforward: tobacco use is still the leading preventable cause of illness and death in the United States, and while more than half of people who smoke try to quit each year, fewer than one in ten are successful. There are well-established, evidence-based cessation tools, including individual, group, and telephone counseling, seven FDA-approved cessation medications, and digital supports like web- and text-based interventions, but they are not used as widely or as effectively as they could be.

This opportunity is set up as a competitive, non-research cooperative agreement. That means the work is centered on real-world public health implementation rather than conducting research studies, and recipients should expect an active relationship with CDC through training, guidance, and technical assistance. The overall aim is capacity building: strengthening the ability of state and territorial tobacco control programs (and the organizations they work with) to translate cessation science into practical interventions that increase both quit attempts and quit success among people who use tobacco products.

A major emphasis of the program is reducing disparities in tobacco use and quitting outcomes. The training and technical assistance funded through this award is intended to prioritize interventions that reach groups disproportionately affected by tobacco use and cessation-related inequities. In practice, this points applicants toward strategies that are not only evidence-based, but also designed to be accessible, culturally responsive, and capable of reaching populations that have historically been left behind by cessation systems.

The funded work is organized around the three cessation goal areas described in CDCs Best Practices for Comprehensive Tobacco Control Programs (2014). First, it supports health systems change to make evidence-based tobacco dependence treatment part of routine clinical care, such as standardizing screening for tobacco use, embedding referral pathways, and expanding consistent delivery of counseling and medication. Second, it focuses on improving insurance coverage for evidence-based cessation treatments and increasing actual utilization of those covered services, recognizing that coverage gaps, administrative barriers, and low awareness can prevent people from accessing proven help. Third, it strengthens state quitline capacity, reflecting the ongoing role quitlines play as a scalable, population-level cessation service that can connect people to counseling, follow-up, and sometimes medication support depending on state policy and resources.

The period of performance is projected to be 60 months (five years), structured into five 12-month budget periods. CDC expects to make three awards. Each award is projected at about $300,000 per 12-month budget period. The listing indicates an award ceiling of $9,000,000, though the program description frames anticipated annual budgets at the $300,000 level for each of the three recipients.

Eligibility is broad and includes state, county, and local governments; tribal governments and tribal organizations; public housing authorities; K-12 independent school districts; public and private institutions of higher education; nonprofit organizations with or without 501(c)(3) status; for-profit organizations (including small businesses); and other unrestricted applicants. The funding activity category is health, under CFDA 93.348, and the issuing agency is the Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion. The original closing date listed for applications is April 24, 2024, and the opportunity was created on February 21, 2024.

• The Centers for Disease Control - NCCDPHP in the health sector is offering a public funding opportunity titled "Building Capacity to Increase Commercial Tobacco Cessation" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.348.
• This funding opportunity was created on 2024-02-21.
• Applicants must submit their applications by 2024-04-24. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• Each selected applicant is eligible to receive up to $9,000,000.00 in funding.
• The number of recipients for this funding is limited to 3 candidate(s).
• Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others, Unrestricted.

Apply for CDC RFA DP 24 0056

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: